Biogaia (BIOG B.ST) Stock Price

Biogaia Price

OMX·CLOSED
113.50
​
Market closed

Over the last 19 years Biogaia grew revenue by 16.3% annually, reaching 1.54 B SEK. Earnings per share have grown at 28.8% per year over the last 19 years. For Biogaia, the net margin of 21.6% is down versus 25.0% a few years ago. At today's price the dividend yield works out to roughly 6.08%. The payout ratio is around 210% of earnings. The dividend has grown at 32.1% per year over the past 16 years. The consensus 12-month price target for Biogaia is 137.70 SEK, about 21.3% above where the stock trades today. Of 6 analysts, 5 rate the stock a buy — an overall Buy consensus.

Biogaia stock price

Access this data via the Eulerpool API

Biogaia business model & stock analysis

BioGaia AB engages in the development, marketing, and sale of probiotic products. The company is headquartered in Stockholm, Stockholm and currently employs 158 full-time employees. The firm develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The firm operates worldwide.

Frequently asked questions about Biogaia

Analysts currently set an average price target of 137.70 SEK for the Biogaia stock (median: 137.70 SEK), implying +21.3 % versus the latest price. The consensus is based on 6 analyst ratings.

6 analysts currently rate the Biogaia stock: 5 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Biogaia to generate revenue of 1.67 B SEK and earnings per share of 3.83 SEK.

Converted at the current exchange rate, the Biogaia share trades at 10.13 EUR (113.50 SEK).

The Biogaia share (BIOG B.ST) is listed on 1 stock exchanges, including: Stockholm (BIOG-B.ST).

The expected revenue of Biogaia is 1.67 B SEK. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Biogaia is 386.94 M SEK. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Biogaia is currently 29.67. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Biogaia stock.

The price-to-sales ratio (P/S) of Biogaia is currently 6.88. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Biogaia stock.

The Eulerpool Quality Score for Biogaia is 6/10.

The ISIN of Biogaia is SE0017769995. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Biogaia is 914755. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Biogaia is BIOG B.ST. The ticker symbol is used to trade Biogaia shares on the stock exchange.

Fair ValueTerminal
114.64 SEK
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
9.74 M SEK
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website biogaia.se
Country
Sweden
Currency
SEK
Initial public offering
Jan 1, 1998
ISIN
SE0017769995
Cusip
W16746153
Sedol
5473124
Market capitalization
11.48 B SEKLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
29.67
P/Ee 2027
24.20
P/Ee 2028
—
P/S
P/Se
6.88
EV/EBIT
23.97
P/B Ratio
8.74
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
25.19 %
Dividend
Dividend yield
6.08 %
Est. Dividend Yield
3.52 %
Payout Ratio
209.76 %
Dividend growth Ø5Y
6.04 %
Dividend payments per year
1
Dividend paid since
17 years
Dividend not reduced since
2 years
Dividend increased since
0 years
Dividend withholding tax
30.00 %
Last updated Oct 8, 2026, 5:18 PM

All fundamentals and in-depth analysis of Biogaia

Our stock analysis for Biogaia stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biogaia. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.